About Synergen Pharma India Private Limited
Data last updated:
Synergen Pharma India Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Synergen Asia Pte Ltd. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2015PTC101824. Its GSTIN is 33AAWCS0606F1ZF (Tamil Nadu).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.49 Cr. It is led by directors including Senthil Nathan Balasubramanian and Sankara Vijjaya Krishnan Hariharan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F.No. 12 N.D.No.10 19/12 Bazulluah Road Theyagarayar Nagar, Chennai, Tamil Nadu, India – 600017.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.85 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹5.43 Lakh (net margin 2.9%) and EBITDA of ₹7.86 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 9% over five years.
The company has about 16 employees on its provident fund (EPFO) records.
The company has 2 deals on record (2 rights issues); the latest was in April 2016.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synergenpharma.com.
Company details
Contact details
Synergen Pharma India Private Limited's registered office is in Chennai, Tamil Nadu. Its website is synergenpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressF.No. 12 N.D.No.10 19/12 Bazulluah Road Theyagarayar Nagar, Chennai, Tamil Nadu, India – 600017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Synergen Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synergen Pharma India is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Synergen Pharma India Private Limited, buy the company report.
Financials of Synergen Pharma India Private Limited
FY 2025 filings availableSynergen Pharma India Private Limited reported revenue of ₹1.85 Cr (up 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 25% growth in the latest year. EBITDA rose 66% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.43 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synergen Pharma India Private Limited, buy the company report.
Board of directors of Synergen Pharma India Private Limited
Synergen Pharma India has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Senthil Nathan Balasubramanian | Director | 11 Mar 2016 | 10 Years 8 Months | Current |
| Sankara Vijjaya Krishnan Hariharan | Director | 23 Nov 2017 | 8 Years 11 Months | Current |
| Sankaraviswanathan Kalyanasundaram Also directs: Visaka Business Solutions (OPC) Private Limited | Director | 13 Aug 2015 | 11 Years 3 Months | Current |
Auditor
Synergen Pharma India Private Limited is audited by S L S M & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S L S M & CO | FY 2020 | 003729S |
Shareholding
The shareholding of Synergen Pharma India Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Synergen Pharma India Private Limited, buy the company report.
Deals & funding
Synergen Pharma India Private Limited has 2 deals on record (2 rights issues); the latest was in April 2016.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2016 | Rights issue | ₹34 Lakh | Investors: Synergen Asia Pte Limited |
| Dec 2015 | Rights issue | ₹65 Lakh | Investors: Synergen Asia Pte Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Synergen Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synergen Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Synergen Pharma India Private Limited has a workforce of 16 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 16 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Synergen Pharma India Private Limited, buy the company report.
GST
Synergen Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAWCS0606F1ZF | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Synergen Pharma India Private Limited, buy the company report.
Recent activity
Synergen Pharma India Private Limited has 6 board changes on record since 2015: 3 appointments and 3 cessations. The latest: Mrithinjayam Venkateswaran ceased to be Director on 01 Feb 2024.
Frequently asked questions
Synergen Pharma India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 August 2015 (11+ years old) and is registered under CIN U24100TN2015PTC101824.
Synergen Pharma India has 3 current directors:
- Senthil Nathan Balasubramanian - Director
- Sankara Vijjaya Krishnan Hariharan - Director
- Sankaraviswanathan Kalyanasundaram - Director
The latest financial statements of Synergen Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Synergen Pharma India is 33AAWCS0606F1ZF, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Synergen Pharma India is U24100TN2015PTC101824. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synergen Pharma India was incorporated on 13 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
Synergen Pharma India has 2 deals on record (2 rights issues); the latest was in April 2016.
Mrithinjayam Venkateswaran ceased to be Director on 01 Feb 2024. Sankara Vijjaya Krishnan Hariharan ceased to be Additional Director on 23 Jul 2018. Sankara Vijjaya Krishnan Hariharan was appointed as Director on 23 Nov 2017. Synergen Pharma India has 6 board changes on record in total.
Synergen Pharma India can be reached through the website synergenpharma.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Synergen Pharma India is at F.No. 12 N.D.No.10 1912 Bazulluah Road Theyagarayar Nagar, Chennai, Tamil Nadu, India – 600017.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
